Pages that link to "Q34658718"
Jump to navigation
Jump to search
The following pages link to Familial pancreatic cancer: genetic advances (Q34658718):
Displaying 39 items.
- Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer (Q28066320) (← links)
- An Overview of Genetic Changes and Risk of Pancreatic Ductal Adenocarcinoma (Q28076342) (← links)
- Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward (Q33624574) (← links)
- Current Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer (Q33821218) (← links)
- Targeting reactive nitrogen species suppresses hereditary pancreatic cancer (Q33887034) (← links)
- Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer (Q34422252) (← links)
- Elevated DNA damage response in pancreatic cancer (Q34566631) (← links)
- Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer (Q35671422) (← links)
- Prognostic Significance of Nuclear Phospho-ATM Expression in Melanoma (Q35746569) (← links)
- Pancreatic cancer stromal biology and therapy (Q35766799) (← links)
- A concise review on the current understanding of pancreatic cancer stem cells (Q35801362) (← links)
- Therapeutic opportunities within the DNA damage response (Q38364665) (← links)
- Pancreatic cancer: current understanding of molecular and genetic aetiologies (Q38540431) (← links)
- Pancreatic cancer: BRCA mutation and personalized treatment (Q38592167) (← links)
- Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers (Q38682057) (← links)
- IKBKE Is Required during KRAS-Induced Pancreatic Tumorigenesis (Q38722219) (← links)
- Differential Potential of Pharmacological PARP Inhibitors for Inhibiting Cell Proliferation and Inducing Apoptosis in Human Breast Cancer Cells (Q38874006) (← links)
- Pancreatic cancer actionable genes in precision medicine and personalized surgery (Q38884916) (← links)
- The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and Prognosis Biomarker for Pancreatic Cancer (Q39080898) (← links)
- A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes (Q39126045) (← links)
- Association of melanoma with intraepithelial neoplasia of the pancreas in three patients. (Q44297191) (← links)
- Pancreatic Cancer Screening (Q48594379) (← links)
- Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview (Q57091632) (← links)
- Germline Variants and Risk for Pancreatic Cancer: A Systematic Review and Emerging Concepts (Q57165768) (← links)
- Identification of patients with pancreatic adenocarcinoma due to inheritable mutation: Challenges of daily clinical practice (Q61795973) (← links)
- Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood (Q64070996) (← links)
- Inactivation of XPF Sensitizes Cancer Cells to Gemcitabine (Q64071352) (← links)
- TAMing pancreatic cancer: combat with a double edged sword (Q64100384) (← links)
- Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer (Q64277715) (← links)
- Pancreatic cancer (Q87198210) (← links)
- Is There a Trojan Horse to Aggressive Pancreatic Cancer Biology? A Review of the Trypsin-PAR2 Axis to Proliferation, Early Invasion, and Metastasis (Q89738383) (← links)
- Developing effective combination therapy for pancreatic cancer: An overview (Q90066525) (← links)
- PRSS1 mutation: a possible pathomechanism of pancreatic carcinogenesis and pancreatic cancer (Q90106815) (← links)
- Tissue specificity of DNA damage response and tumorigenesis (Q90357642) (← links)
- Characterization of novel genetic alterations in salivary gland secretory carcinoma (Q91855473) (← links)
- RAD51 is a potential marker for prognosis and regulates cell proliferation in pancreatic cancer (Q92340232) (← links)
- Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer (Q92578790) (← links)
- Systematic Identification of Characteristic Genes of Ovarian Clear Cell Carcinoma Compared with High-Grade Serous Carcinoma Based on RNA-Sequencing (Q93126756) (← links)
- Characteristics of early-onset pancreatic cancer and its association with familial pancreatic cancer and hereditary pancreatic cancer syndromes (Q96111365) (← links)